Efficacy of Ginger in Ameliorating Acute and Delayed Chemotherapy-Induced Nausea and Vomiting Among Patients With Lung Cancer Receiving Cisplatin-Based Regimens: A Randomized Controlled Trial

Nausea and vomiting are among the most common and distressing side effects of chemotherapy. Additional antiemetic drugs are urgently needed to effectively manage and ameliorate chemotherapy-induced nausea and vomiting (CINV). The efficacy of ginger as an antiemetic modality for ameliorating CINV has...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xiangfeng, Qin, Ying, Liu, Wei, Zhou, Xiao-yu, Li, Ya-nan, Wang, Li-ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6142108/
https://www.ncbi.nlm.nih.gov/pubmed/29417850
http://dx.doi.org/10.1177/1534735417753541
_version_ 1783355808517455872
author Li, Xiangfeng
Qin, Ying
Liu, Wei
Zhou, Xiao-yu
Li, Ya-nan
Wang, Li-ying
author_facet Li, Xiangfeng
Qin, Ying
Liu, Wei
Zhou, Xiao-yu
Li, Ya-nan
Wang, Li-ying
author_sort Li, Xiangfeng
collection PubMed
description Nausea and vomiting are among the most common and distressing side effects of chemotherapy. Additional antiemetic drugs are urgently needed to effectively manage and ameliorate chemotherapy-induced nausea and vomiting (CINV). The efficacy of ginger as an antiemetic modality for ameliorating CINV has not been established in previous studies. The aim of this study was to examine the efficacy of ginger, as an adjuvant drug to standard antiemetic therapy, in ameliorating acute and delayed CINV in patients with lung cancer receiving cisplatin-based regimens. In this randomized, double-blind, placebo-controlled clinical trial, 140 patients with lung cancer receiving cisplatin-based regimens were enrolled and allocated to receive either ginger root powder or a placebo. Ginger root powder was administered orally (0.5 g, 2 capsules per day, 0.25 g per capsule, every 12 hours) for 5 days beginning on the first day of chemotherapy. The incidence and severity of acute and delayed nausea and vomiting were assessed using the MASCC (Multinational Association for Supportive Care in Cancer) Antiemesis Tool (MAT). Adverse effects and patient adherence were also assessed in this study. No significant difference was observed between the ginger and control groups in the reduction of the incidence and severity of nausea and vomiting (P > .05). No significant difference in adverse events was observed between the 2 groups (P > .05). No study-treatment-related adverse events were observed in this study. As an adjuvant drug to standard antiemetic therapy, ginger had no additional efficacy in ameliorating CINV in patients with lung cancer receiving cisplatin-based regimens.
format Online
Article
Text
id pubmed-6142108
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-61421082018-09-20 Efficacy of Ginger in Ameliorating Acute and Delayed Chemotherapy-Induced Nausea and Vomiting Among Patients With Lung Cancer Receiving Cisplatin-Based Regimens: A Randomized Controlled Trial Li, Xiangfeng Qin, Ying Liu, Wei Zhou, Xiao-yu Li, Ya-nan Wang, Li-ying Integr Cancer Ther Research Articles Nausea and vomiting are among the most common and distressing side effects of chemotherapy. Additional antiemetic drugs are urgently needed to effectively manage and ameliorate chemotherapy-induced nausea and vomiting (CINV). The efficacy of ginger as an antiemetic modality for ameliorating CINV has not been established in previous studies. The aim of this study was to examine the efficacy of ginger, as an adjuvant drug to standard antiemetic therapy, in ameliorating acute and delayed CINV in patients with lung cancer receiving cisplatin-based regimens. In this randomized, double-blind, placebo-controlled clinical trial, 140 patients with lung cancer receiving cisplatin-based regimens were enrolled and allocated to receive either ginger root powder or a placebo. Ginger root powder was administered orally (0.5 g, 2 capsules per day, 0.25 g per capsule, every 12 hours) for 5 days beginning on the first day of chemotherapy. The incidence and severity of acute and delayed nausea and vomiting were assessed using the MASCC (Multinational Association for Supportive Care in Cancer) Antiemesis Tool (MAT). Adverse effects and patient adherence were also assessed in this study. No significant difference was observed between the ginger and control groups in the reduction of the incidence and severity of nausea and vomiting (P > .05). No significant difference in adverse events was observed between the 2 groups (P > .05). No study-treatment-related adverse events were observed in this study. As an adjuvant drug to standard antiemetic therapy, ginger had no additional efficacy in ameliorating CINV in patients with lung cancer receiving cisplatin-based regimens. SAGE Publications 2018-02-08 /pmc/articles/PMC6142108/ /pubmed/29417850 http://dx.doi.org/10.1177/1534735417753541 Text en © The Author(s) 2018 http://www.creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Research Articles
Li, Xiangfeng
Qin, Ying
Liu, Wei
Zhou, Xiao-yu
Li, Ya-nan
Wang, Li-ying
Efficacy of Ginger in Ameliorating Acute and Delayed Chemotherapy-Induced Nausea and Vomiting Among Patients With Lung Cancer Receiving Cisplatin-Based Regimens: A Randomized Controlled Trial
title Efficacy of Ginger in Ameliorating Acute and Delayed Chemotherapy-Induced Nausea and Vomiting Among Patients With Lung Cancer Receiving Cisplatin-Based Regimens: A Randomized Controlled Trial
title_full Efficacy of Ginger in Ameliorating Acute and Delayed Chemotherapy-Induced Nausea and Vomiting Among Patients With Lung Cancer Receiving Cisplatin-Based Regimens: A Randomized Controlled Trial
title_fullStr Efficacy of Ginger in Ameliorating Acute and Delayed Chemotherapy-Induced Nausea and Vomiting Among Patients With Lung Cancer Receiving Cisplatin-Based Regimens: A Randomized Controlled Trial
title_full_unstemmed Efficacy of Ginger in Ameliorating Acute and Delayed Chemotherapy-Induced Nausea and Vomiting Among Patients With Lung Cancer Receiving Cisplatin-Based Regimens: A Randomized Controlled Trial
title_short Efficacy of Ginger in Ameliorating Acute and Delayed Chemotherapy-Induced Nausea and Vomiting Among Patients With Lung Cancer Receiving Cisplatin-Based Regimens: A Randomized Controlled Trial
title_sort efficacy of ginger in ameliorating acute and delayed chemotherapy-induced nausea and vomiting among patients with lung cancer receiving cisplatin-based regimens: a randomized controlled trial
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6142108/
https://www.ncbi.nlm.nih.gov/pubmed/29417850
http://dx.doi.org/10.1177/1534735417753541
work_keys_str_mv AT lixiangfeng efficacyofgingerinamelioratingacuteanddelayedchemotherapyinducednauseaandvomitingamongpatientswithlungcancerreceivingcisplatinbasedregimensarandomizedcontrolledtrial
AT qinying efficacyofgingerinamelioratingacuteanddelayedchemotherapyinducednauseaandvomitingamongpatientswithlungcancerreceivingcisplatinbasedregimensarandomizedcontrolledtrial
AT liuwei efficacyofgingerinamelioratingacuteanddelayedchemotherapyinducednauseaandvomitingamongpatientswithlungcancerreceivingcisplatinbasedregimensarandomizedcontrolledtrial
AT zhouxiaoyu efficacyofgingerinamelioratingacuteanddelayedchemotherapyinducednauseaandvomitingamongpatientswithlungcancerreceivingcisplatinbasedregimensarandomizedcontrolledtrial
AT liyanan efficacyofgingerinamelioratingacuteanddelayedchemotherapyinducednauseaandvomitingamongpatientswithlungcancerreceivingcisplatinbasedregimensarandomizedcontrolledtrial
AT wangliying efficacyofgingerinamelioratingacuteanddelayedchemotherapyinducednauseaandvomitingamongpatientswithlungcancerreceivingcisplatinbasedregimensarandomizedcontrolledtrial